David Sluss, Ph.D.
Associate Professor of Organizational Behavior
Scheller College of Business, Georgia Institute of Technology
David M. Sluss, Ph.D. educates and coaches high potential executives on how to become agile, adaptive, & analytical leaders - to influence others for high performance and organizational transformation. He focuses on ‘new leader’ development and transitions as well as building leader resilience in the face of adversity. He takes a diagnostic and behavioral approach to facilitating leadership development. He enjoys helping high-potential professionals and executives prepare themselves for their next role.
His research (see google scholar) focuses on creating personalized and productive relationships - particularly between leaders and newcomers as well as leaders and more tenured employees. He explores these processes across different contexts: telemarketing newcomers, technical professionals, contingent workers, and nomadic professionals. He has published research in the Academy of Management Journal, Academy of Management Review, Journal of Applied Psychology, Journal of Vocational Behavior, and Organization Science. He is currently serving on the editorial boards for Academy of Management Review, Journal of Applied Psychology, and Journal of Management.
He works with organizations throughout the U.S., Latin America, and Europe. Fluent in Spanish, he has worked in Mexico, Puerto Rico, and Colombia. A partial list includes: Abbott Laboratories (U.S. and Puerto Rico), Argos (Colombia), Baxter Pharmaceuticals (Belgium), Cisco Systems, Clorox, Coca-Cola, Google, IBM (U.S. & Ireland), McKesson, Rohlig (Germany), SCTE, Simpson Industries (Mexico), OSCE, A1 (Austria), and Verbund (Austria).
Prior to his doctoral studies, he was Vice President and Partner at PathWise (a boutique management training consultancy). He designed and facilitated "real-life" application workshops on topics such as leadership, performance coaching, problem solving/decision making, and project management for clients within the technology and pharmaceutical sectors.